IPCA Laboratories Ltd dials into Lyka Labs Ltd

Leading Indian pharmaceutical company IPCA Laboratories Ltd (IPCA) has purchased 1,050,000 equity shares of Lyka Labs Ltd, another pharmaceutical company which has been on a financial turnaround in the recent quarters. IPCA purchased the shares at a price of Rs. 123 per share through market purchase on Nov 22, 2021.

Shreyans Jashwantlal Shah had sold 345,000 equity shares at a price of Rs. 123 per share and Vipul Priyakant Dalal has sold 240,121 equity shares at a price of Rs. 123 per share.

Shares of IPCA Laboratories Limited was last trading in BSE at Rs. 2030.35 as compared to the previous close of Rs. 2078.30. The total number of shares traded during the day was 13194 in over 2474 trades.

The stock hit an intraday high of Rs. 2104.20 and intraday low of 2023.00. The net turnover during the day was Rs. 27091213.00.

Shares of Lyka Labs Limited was last trading in BSE at Rs. 123.00 as compared to the previous close of Rs. 117.15. The total number of shares traded during the day was 1287046 in over 1542 trades.

The stock hit an intraday high of Rs. 123.00 and intraday low of 118.10. The net turnover during the day was Rs. 158212667.00.

Source : Equity Bulls

Keywords

IPCALaboratoriesLimited INE571A01020 IPCALAB Pharmaceuticals LykaLabsLimited INE933A01014 BulkDeal MarketPurchase